Bristol-Myers Squibb (BMS) Total Revenue: $48.19B Founded Year: 1887 Total Employees: 32,500 Headquarters: New Jersey, United States Market Cap: $121.42B Stock Exchange: NYSE BMS is a global biopharma company focused on oncology, hematology, immunology, and cardiovascular diseases, with a strong portfolio of innovative therapies and a legacy of blockbuster drugs
Pharmacological management of obesity: an Endocrine Society clinical practice guideline
Asia Pacific is expected to witness rapid growth due to expanding healthcare access and increasing awareness regarding metabolic disease management
What's most exciting isn't just the market performance of these companiesit's the impact their innovations are having on patients facing some of the most challenging diseases and conditions
The market is expanding at a CAGR of 5.28% between 2025 and 2034
Most patients experience some degree of gastrointestinal adjustment when initiating weight loss injections